Celldex Doses First Patient in Phase 1b Study of CDX-0159 in Chronic Inducible Urticaria
HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been...
News
Biotricity to Present at the 13th Annual LD Micro Main Event and Host Virtual One-on-One Meetings with Investors
REDWOOD CITY, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company,...
Delcath Systems Announces Pricing of Public Offering of Common Stock
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
Protech Home Medical Announces New Independent Board Member
Dr. Kevin A. Carter Appointed to Board of DirectorsCINCINNATI, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech”...
EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of...
ImmunoGenesis: Acquisition Strengthens “Cold” Tumor Targeting Pipeline
ImmunoGenesis acquires rights to evofosfamide; Phase 2 clinical testing in combination with checkpoint blockade is planned for 2021.Evofosfamide is the only...
Intra-Cellular Therapies Highlights Lumateperone Presentations at the 59th Annual Meeting of the American College of Neuropsychopharmacology
Presentations highlight lumateperone’s broad antidepressant effects in patients with bipolar disorder and in patients with schizophrenia with co-morbid depression NEW...
Prothena Reports Positive 9 Month Results from Phase 1 Long-term Extension Study of PRX004, the First Investigational Anti-Amyloid Immunotherapy for the Treatment of ATTR Amyloidosis
Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a +1.29 point mean change in NIS, was more...
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
Increases Size of Facility and Extends Interest-Only Period Enabling ADMA to Reach Profitability Prior to Maturity Demonstrates Perceptive’s Commitment and...
Tongji Healthcare Group, Inc. Signs Definitive Agreement to Acquire Magiclytics, Disruptive Platform for Influencer-Based Marketing Strategies
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Tongji Healthcare Group, Inc. (OTCMKTS:TONJ) (Name Change to “Clubhouse...
Proposal of candidates to the Board of Directors
Please read the full announcement in PDF Attachment 2020_63_Proposal_of_candidates_to_the_Board_of_Directors
RA Capital Management Leads $45M Series A Financing for PepGen’s Next-Generation Oligonucleotide Platform Targeting Duchenne Muscular Dystrophy and Other Rare Neuromuscular and Cardiac Diseases
PepGen’s proprietary cell-penetrating peptide technology promises enhanced safety, efficacy, and improved delivery to cardiac muscle; Oxford Sciences Innovation, The University...
OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
Dr. Arne Materna to join Ares Genetics as new Managing Director and CEO to lead Ares into next phase of...
VitalHub Announces Addition of Award-Winning Synopsis iQ to Recently Expanded Multi-Year Licensing Deal with King’s College Hospital NHS Foundation Trust
TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the...
Cytokinetics Announces Progression of REDWOOD-HCM to Cohort 2
Interim Analysis of Data from Cohort 1 Demonstrate Substantial Effects of CK-274 to Reduce LVOT Gradient in Patients with Obstructive...
POINT Biopharma Announces New Board Appointments
Jonathan Ross Goodman, Gerry Hogue and Peggy Gilmour join POINT’s Board of Directors TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) --...
CMR Surgical- Strong Commercial Progress in India and the Middle East
Strong Commercial Progress in India and the Middle East ·Versius has been adopted by a number of new hospitals, making...
Skylight Health Announces New OTCQX Ticker and Presentation at LD Micro in December
Skylight Health will begin trading under new ticker “SHGFF” on the OTCQX December 9, 2020Company continues to trade under “SHG”...
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation
- SoniVie Acquires New Intellectual Property and Other Assets from Cardiosonic Moving TIVUS into New Therapeutic Areas Beyond Pulmonary Hypertension...
Fulcrum Therapeutics to Host Virtual Key Opinion Leader Event Featuring FTX-6058 for Sickle Cell Disease
Event will review the company’s novel approach to inducing fetal hemoglobin Live webcast on December 15, 2020 at 8:30am ET...